Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0R2HF
|
||||
Former ID |
DNC013517
|
||||
Drug Name |
6-(2-mercaptoacetamido)-N-phenylhexanamide
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529285] | ||
Structure |
Download2D MOL |
||||
Formula |
C14H20N2O2S
|
||||
Canonical SMILES |
C1=CC=C(C=C1)NC(=O)CCCCCNC(=O)CS
|
||||
InChI |
1S/C14H20N2O2S/c17-13(16-12-7-3-1-4-8-12)9-5-2-6-10-15-14(18)11-19/h1,3-4,7-8,19H,2,5-6,9-11H2,(H,15,18)(H,16,17)
|
||||
InChIKey |
ICMLRCZXRBTKLJ-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Histone Deacetylase 8 | Target Info | Inhibitor | [529285] | |
KEGG Pathway | Alcoholism | ||||
Viral carcinogenesis | |||||
PANTHER Pathway | Wnt signaling pathway | ||||
Pathway Interaction Database | Signaling events mediated by HDAC Class I | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.